University of Kansas Medical Center
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1906-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- https://www.kumc.edu
MOD Diet in Gestational Diabetes Mellitus
Not Applicable
Terminated
- Conditions
- Gestational Diabetes
- Interventions
- Other: Standard Care DietOther: MOD Diet
- First Posted Date
- 2020-09-30
- Last Posted Date
- 2022-09-10
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 6
- Registration Number
- NCT04570111
- Locations
- πΊπΈ
University of Kansas Medical Center, Kansas City, Kansas, United States
COVID-19 Biorepository
Active, not recruiting
- Conditions
- Covid-19SARS-CoV 2CoronavirusCOVID
- First Posted Date
- 2020-09-29
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 201
- Registration Number
- NCT04568148
- Locations
- πΊπΈ
University of Kansas Medical Center, Kansas City, Kansas, United States
Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer
Active, not recruiting
- Conditions
- Bladder Cancer
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 9
- Registration Number
- NCT04567719
- Locations
- πΊπΈ
The University of Kansas Medical Center, Kansas City, Kansas, United States
πΊπΈThe University of Kansas Cancer Center, Westwood Campus, Kansas City, Kansas, United States
Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Comparing Post-Operative Incontinence Rates and Surgical Outcomes
Not Applicable
Completed
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Procedure: Classic HoLEPProcedure: EAR HoLEP
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT04566588
- Locations
- πΊπΈ
University of Kansas Health System, Kansas City, Kansas, United States
Effects of Innovative Aerobic Exercise Training in Cystic Fibrosis
Not Applicable
Completed
- Conditions
- Cystic Fibrosis
- Interventions
- Behavioral: exercise
- First Posted Date
- 2020-09-10
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 9
- Registration Number
- NCT04543929
- Locations
- πΊπΈ
University of Kansas Medical Center, Kansas City, Kansas, United States
Effects of Metformin on Airway Ion Channel Dysfunction in Cystic Fibrosis-related Diabetes
Phase 2
Recruiting
- Conditions
- Cystic FibrosisCystic Fibrosis-related Diabetes
- Interventions
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 36
- Registration Number
- NCT04530383
- Locations
- πΊπΈ
University of Kansas Medical Center, Kansas City, Kansas, United States
Investigating the Effect of Interval Walking and Qigong on People With Knee Osteoarthritis: Pilot Study
Not Applicable
- Conditions
- Osteoarthritis, Knee
- Interventions
- Behavioral: Interval walking and Qigong exercise
- First Posted Date
- 2020-08-27
- Last Posted Date
- 2022-05-26
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT04528953
- Locations
- πΊπΈ
Wen Liu, Kansas City, Kansas, United States
A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)
- First Posted Date
- 2020-07-22
- Last Posted Date
- 2021-06-23
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT04481685
- Locations
- πΊπΈ
The University of Kansas Medical Center, Kansas City, Kansas, United States
Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy
Phase 2
Not yet recruiting
- Conditions
- Chronic Inflammatory Demyelinating Polyneuropathy
- Interventions
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 44
- Registration Number
- NCT04480450
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT04467723
- Locations
- πΊπΈ
The University of Kansas Cancer Center (KUCC), Fairway, Kansas, United States
πΊπΈThe University of Kansas Cancer Center, Westwood Campus, Kansas City, Kansas, United States
Β© Copyright 2025. All Rights Reserved by MedPath